e8vk
 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549


FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the
Securities Exchange Act of 1934

     
Date of Report (Date of earliest event reported):
  February 24, 2004

United Therapeutics Corporation

(Exact Name of Registrant as Specified in Charter)

         
Delaware   000-26301   52-1984749

 
 
 
 
 
(State or Other
Jurisdiction of
Incorporation)
  (Commission
File Number)
  (I.R.S. Employer
Identification Number)
     
1110 Spring Street
Silver Spring, MD
  20910

 
 
 
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code:

(301) 608-9292

 


 

Item 12. Earnings Announcements or Releases.

     On February 24, 2004, United Therapeutics Corporation (the “Company”) issued a press release setting forth its earnings for the Company’s quarterly fiscal period and year ended December 31, 2003. A copy of this press release is attached hereto as Exhibit 99.1. The Company does not intend for Exhibit 99.1 to be incorporated by reference into filings under the Securities Act of 1933 or the Securities Exchange Act of 1934.

Item 7. Exhibits

(c) Exhibits

     
Exhibit No.
  Description of Exhibit

 
 
 
 99.1
  Press release dated February 24, 2004

 


 

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

             
  UNITED THERAPEUTICS CORPORATION    
             
Dated: February 24, 2004
  By:

Name:
Title:
  /s/ Paul A. Mahon

Paul A. Mahon
General Counsel
   

 


 

EXHIBIT INDEX

     
Exhibit No.
  Description of Exhibit

 
 
 
99.1
  Press release dated February 24, 2004